Literature DB >> 15288162

Expert consensus document on beta-adrenergic receptor blockers.

José López-Sendón1, Karl Swedberg, John McMurray, Juan Tamargo, Aldo P Maggioni, Henry Dargie, Michal Tendera, Finn Waagstein, Jan Kjekshus, Philippe Lechat, Christian Torp-Pedersen.   

Abstract

Mesh：

Substances：

Year:  2004        PMID： 15288162     DOI： 10.1016/j.ehj.2004.06.002

Source DB:  PubMed          Journal:  Eur Heart J        ISSN： 0195-668X            Impact factor:   29.983


× No keyword cloud information.
  112 in total

1.  Remodelling of human atrial K+ currents but not ion channel expression by chronic β-blockade.

Authors:  Gillian E Marshall; Julie A Russell; James O Tellez; Pardeep S Jhund; Susan Currie; John Dempster; Mark R Boyett; Kathleen A Kane; Andrew C Rankin; Antony J Workman
Journal:  Pflugers Arch       Date:  2011-12-08       Impact factor: 3.657

Review 2.  The role of Beta-blockers as first-line therapy in hypertension.

Authors:  Alberto Ranieri De Caterina; Antonio Maria Leone
Journal:  Curr Atheroscler Rep       Date:  2011-04       Impact factor: 5.113

Review 3.  Impact of Antihypertensive Agents on Central Systolic Blood Pressure and Augmentation Index: A Meta-Analysis.

Authors:  Tracey J McGaughey; Emily A Fletcher; Sachin A Shah
Journal:  Am J Hypertens       Date:  2015-08-19       Impact factor: 2.689

4.  Cardiac ischemia-reperfusion regulates sympathetic neuropeptide expression through gp130-dependent and independent mechanisms.

Authors:  Eric N Alston; Diana C Parrish; Wohaib Hasan; Kevin Tharp; Laura Pahlmeyer; Beth A Habecker
Journal:  Neuropeptides       Date:  2010-10-28       Impact factor: 3.286

5.  Hypertrophic cardiomyopathy. Combination of beta blockers and verapamil may be risky.

Authors:  Javier Borja; Iñaki Izquierdo; Josep Guindo
Journal:  BMJ       Date:  2006-07-08

6.  Missed opportunities for the secondary prevention of cardiovascular disease in Canada.

Authors:  Daniel G Hackam; Lawrence A Leiter; Andrew T Yan; Raymond T Yan; Aurora Mendelsohn; Mary Tan; Louis Zavodni; Richard Chen; Jennifer L Tsang; Anjali Kundi; Peter J Lin; David H Fitchett; Anatoly Langer; Shaun G Goodman
Journal:  Can J Cardiol       Date:  2007-12       Impact factor: 5.223

7.  Immortal time bias in pharmacoepidemiological studies on cancer patient survival: empirical illustration for beta-blocker use in four cancers with different prognosis.

Authors:  Janick Weberpals; Lina Jansen; Myrthe P P van Herk-Sukel; Josephina G Kuiper; Mieke J Aarts; Pauline A J Vissers; Hermann Brenner
Journal:  Eur J Epidemiol       Date:  2017-09-01       Impact factor: 8.082

Review 8.  The sympathetic nervous system and heart failure.

Authors:  David Y Zhang; Allen S Anderson
Journal:  Cardiol Clin       Date:  2014-02       Impact factor: 2.213

9.  Trends in adherence to secondary prevention medications in elderly post-myocardial infarction patients.

Authors:  Niteesh K Choudhry; Soko Setoguchi; Raisa Levin; Wolfgang C Winkelmayer; William H Shrank
Journal:  Pharmacoepidemiol Drug Saf       Date:  2008-12       Impact factor: 2.890

Review 10.  Cardiac adrenergic control and atrial fibrillation.

Authors:  Antony J Workman
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2009-12-04       Impact factor: 3.000
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.